We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MRAM:NASDAQEverspin Technologies, Inc. Analysis

Data as of 2026-04-18 - not real-time

$12.37

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Everspin Technologies (MRAM) is trading at $12.37, a level that sits just below its recent resistance of $12.60 and well above the DCF‑derived fair value of roughly $2.80, indicating a substantial premium. The technical suite shows a bullish MACD crossover (MACD line > signal line) but an RSI of 72, signaling that the stock is in overbought territory and may face short‑term pressure. Recent earnings commentary highlights revenue growth of about 12% driven by data‑center, energy‑management, and industrial automation demand, while the company announced expansion of on‑shore manufacturing capacity and a pending CHIPS Act funding application, both of which could support medium‑term top‑line momentum.
On the fundamentals side, the firm posts a negative operating margin and a modest free cash flow generation, with a high forward P/E of 49.5 versus the industry average of 36.7, suggesting the market is pricing in strong future growth despite current losses. Volatility remains elevated (≈64% 30‑day) and beta is high, underscoring heightened market risk, while the balance sheet is solid with $44.5 M cash and minimal debt. Overall, the stock appears overvalued in the near term, but its niche MRAM technology and expanding production footprint provide a compelling long‑term growth narrative.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI in overbought zone
  • Price approaching recent resistance
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Revenue growth from data‑center and industrial segments
  • On‑shore capacity expansion
  • Pending CHIPS Act funding support

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic position in emerging MRAM market
  • Strong cash position and low debt
  • Potential upside as technology adoption accelerates

Key Metrics & Analysis

Financial Health

Revenue Growth11.80%
Profit Margin-1.06%
P/E Ratio49.5
ROE-0.89%
ROA-5.01%
Debt/Equity4.84
P/B Ratio4.1
Op. Cash Flow$10.0M
Free Cash Flow$1.1M
Industry P/E36.7

Technical Analysis

TrendNeutral
RSI71.8
Support$8.00
Resistance$12.60
MA 20$9.92
MA 50$10.15
MA 200$9.18
MACDBullish
VolumeIncreasing
Fear & Greed Index90.21

Valuation

Fair Value$2.81
Target Price$12.50
Upside/Downside1.05%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.45
Volatility63.94%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.